Latest CMSC 2016 Coverage
Several participants who began the intervention from a chair were completing the exercise standing up by the end.
Notably, results were achieved without maintenance therapy.
There was a significant association between the average GCIP thickness and MSFC scores.
The new drug shows promise in the treatment of PPMS, for which there are currently no approved treatments.
The material of the device may play a significant role in the relationship.
Patients taking oral DMDs were more likely to experience relapse in the first year.
A comprehensive approach to managing depression may have far-reaching effects.
At follow-up, 22 patients were cognitively impaired compared to 34 at baseline.
Early screening is paramount to identifying patients at risk for suicide.
Neurology Advisor reviews the upcoming agenda for the CMSC annual meeting.
Sign Up for Free e-newsletters
Check out what's trending
Neurology Advisor Articles
- FDA Approves Expanded Treatment Window for Clot Retrieval Device in Acute Ischemic Stroke
- Genetic and Imaging Markers in Migraine: Ready for Prime Time?
- Intracerebral Hemorrhage-Related Hospital Mortality Reduced With Prior NOAC Use
- Resting Tremor Most Common in Early Parkinson Disease
- Erenumab for Episodic Migraine: A Closer Look at the Data
- Updated Ischemic Stroke Guidelines: Expert Takeaways
- Alternative Genetic Risk Variant for Alzheimer Disease Identified
- Advance Directives for Dementia: Honoring Patient Wishes When You Don't Know What They Are
- Ethical Considerations in New Coma Research
- Poor Sleep Associated With Worse PTSD, Chronic Pain in Youth
- Shortcomings in ALS Research: Strategies for Improvement
- Treatments Vary in Trigeminal Neuralgia
- Premature Dementia Risk Increased in Those With Heart Defects
- Are Casual Observers Able to Accurately Localize Areas of Facial Paralysis?
- Adolescents With Chronic Headache May Benefit From Targeted Group Education